# Hemab Therapeutics Holdings IPO (COAG): price, date and first-day trading

> Hemab Therapeutics Holdings (COAG) priced its IPO at $18.00 a share and has traded on Nasdaq since May 1, 2026.

Canonical: https://massive.com/quote/coag/ipo
Data as of: 2026-11-19T09:02:06.875Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## COAG price

| Figure | Value |
| --- | --- |
| Price | $37.95 |
| Change from the IPO price | +110.83% |
| Change today | -2.84% |

## How COAG did against the market

COAG against the market, from its first trade at 12:30 ET to the last trade of the session.

| Measure | Value |
| --- | --- |
| COAG from its first trade | +27.78% |
| Against the market (QQQ) | +27.8 pts |

## The IPO scoreboard

COAG against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Hemab Therapeutics Holdings | $301.5M | +50.00% | +91.67% | +42.03% | +38.78% |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $16 to $18 |
| IPO price | $18.00 |
| Shares offered | 16.75M |
| Money raised | $301.5M |
| Listing date | May 1, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where COAG ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| COAG | $1.83B |

## Insider buying and selling after the IPO

From May 1, 2026 to Nov 19, 2026, 2 COAG insiders reported open-market purchases of $7.3M across 8 filings; no open-market sales were filed.

- Peter Kolchinsky, Director: bought $2.5M, filed May 6, 2026
- Rajeev M. Shah, Director: bought $1.6M, filed May 6, 2026
- Peter Kolchinsky, 10% owner: bought $1.5M, filed Jun 17, 2026
- Peter Kolchinsky, 10% owner: bought $680.0K, filed May 11, 2026
- Rajeev M. Shah, 10% owner: bought $588.5K, filed May 11, 2026

Sales made in the offering itself are left out.

[Who traded and when](https://massive.com/quote/coag/insider-trading.md)

## COAG news

- [Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress](https://www.globenewswire.com/news-release/2026/07/12/3325841/0/en/Hemab-Therapeutics-Presents-New-Clinical-Data-from-HMB-002-in-Von-Willebrand-Disease-and-Introduces-HMB-003-for-Heavy-Menstrual-Bleeding-at-the-ISTH-2026-Congress.html) · GlobeNewswire Inc. · Jul 12, 2026
- [Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares](https://www.benzinga.com/pressreleases/26/05/g52263720/hemab-therapeutics-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-under?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · May 4, 2026

## Filings and the company

Material events that Hemab Therapeutics Holdings has disclosed to the SEC on Form 8-K.

- Nov 10, 2026 · Quarterly earnings ([filing](https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-454414.txt))
- Sep 24, 2026 · Executive compensation change ([filing](https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-401010.txt))
- May 11, 2026 · Director departure ([filing](https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-216699.txt))
- May 4, 2026 · Public offering ([filing](https://www.sec.gov/Archives/edgar/data/2114044/0001193125-26-203988.txt))

## FAQ

### What was the Hemab Therapeutics Holdings IPO price?

$18.00 a share.

### When did Hemab Therapeutics Holdings go public?

Hemab Therapeutics Holdings listed on Nasdaq on May 1, 2026 under the ticker COAG.

### How much did the Hemab Therapeutics Holdings IPO raise?

$301.5M, before any underwriters' option.

### How did Hemab Therapeutics Holdings open on its first day?

COAG first traded at $27.00, +50.00% from the IPO price of $18.00.

### How did COAG close on its first day?

Its last regular-session trade was $34.50, +91.67% from the IPO price of $18.00.

### What was the COAG first-day trading range?

$27.00 to $36.61 in the regular session.

### How many COAG shares traded on the first day?

4.03M shares in the regular session.

### How many shares did Hemab Therapeutics Holdings sell in its IPO?

16.75M shares.

### How did COAG do against the market on its first day?

COAG rose 27.8% from its first trade to the last trade of the session. That is 27.8 points better than the market (QQQ, the Nasdaq-100 ETF).

### What exchange is COAG listed on?

Hemab Therapeutics Holdings lists on Nasdaq under the ticker COAG.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=COAG`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=COAG`
- `GET https://api.massive.com/v2/aggs/ticker/COAG/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
